ArticleBMC ophthalmology2026
Miri 4-points marker: a low-cost marking device for flanged intrascleral intraocular lens fixation with modified Yamane technique.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundYamane's flanged intrascleral intraocular lens (IOL) fixation is widely used in eyes without capsular support, but limitations in conventional conjunctival marking may affect surgical precision and consistency. This study compared the clinical outcomes of modified Yamane scleral-fixated IOL implantation using the Miri 4-Points Marker versus Castroviejo calipers, assessing visual outcomes and complications between these two approaches.
methodsThis retrospective cohort study at a single hospital of Malaysia included 44 eyes operated on between 2024 and 2025. Conjunctival markings were made using either the Miri 4-Points Marker or Castroviejo calipers. Two 30-gauge thin-walled needles created right-angled sclerotomies 2 mm posterior to the limbus. IOL haptics were externalized through the needles, cauterized to form a flange, and inserted into scleral tunnels. Descriptive statistics and binary logistic regression were used to assess factors associated with postoperative visual outcomes.
resultsAmong 44 patients (mean age 64.4 ± 9.7 years, 77.3% male) who underwent intrascleral IOL fixation, the Miri 4-Points Marker was used in 72.7% of cases. Clinical outcomes with the Miri 4-Points Marker were comparable to Castroviejo calipers. Mean postoperative uncorrected visual acuity (UCVA) and corrected distant visual acuity (CDVA) were 0.7 (± 0.4) and 0.4 (± 0.3) logMAR, respectively. At one month postoperatively, 17.2% achieved good UCVA, increasing to 30.8% after excluding ocular comorbidities; 41.4% achieved good CDVA, rising to 46.2% without ocular comorbidities. On univariable analysis, high corneal astigmatism (> 2.5 D) was associated with poorer UCVA across all patients, regardless of Miri 4-Points Marker use (OR = 0.07, 95% CI: 0.01, 0.78, p = 0.03). Multivariable analysis did not identify any independent predictors.
conclusionsThe Miri 4-Points Marker is a feasible and safe adjunct for conjunctival marking in Yamane intrascleral IOL fixation. Observed short-term outcomes were similar to caliper-based marking, although this study's chronological design precludes any conclusion of equivalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.